New directions in brain imaging research in functional gastrointestinal disorders

Digestive Diseases

Volumn 24, Issue 3-4, 2006, Pages 278-285

  Ringel, Yehuda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Brain imaging research, new directions; FGID, brain imaging research; Functional brain imaging; Functional gastrointestinal disorders

Indexed keywords

ALOSETRON; AMITRIPTYLINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; COGNITIVE THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HUMAN; IRRITABLE COLON; MAGNETOENCEPHALOGRAPHY; NEUROIMAGING; NOCICEPTION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSATION; TREATMENT RESPONSE; VISCERAL PAIN;

BIOMEDICAL RESEARCH; BRAIN; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 33746369737     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092881     Document Type: Review

References (51)

1. Ringel Y, Drossman DA: Irritable bowel syndrome: classification and conceptualization. J Clin Gastroenterol 2002;35:S7-S10.
2. Ringel Y, Sperber AD, Drossman AD: Irritable bowel syndrome. Annu Rev Med 2001;52:319-338.
3. Whitehead WE, Palsson O, Jones KR: Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-1156.
4. Palsson OS, Drossman DA: Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005;34:281-303.
5. Van Oudenhove L, Demyttenaere K, Tack J, Aziz Q: Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004;18:663-680.
6. Ringel Y: Brain research in functional gastrointestinal disorders. J Clin Gastroenterol 2002;35(suppl):S23-S25.
7. Villringer A: Understanding functional neuroimaging methods based on neurovascular coupling. Adv Exp Med Biol 1997;413:1977-1993.
8. Lin W, An H, Chen Y, Nicholas P, Zhai G, Gerig G, Gilmore J, Bullitt E: Practical consideration for 3 T imaging. Magn Reson Imaging Clin N Am 2003;11:615-639.
9. Vrba J, Robinson SE: Signal processing in magnetoencephalography. Methods 2001;25:249-271.
10. Hobson AR, Furlong PL, Worthen SF, Hillebrand A, Barnes GR, Singh KD, Aziz Q: Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology 2005;128:610-619.
11. Bromm B, Lorenz J: Neurophysiological evaluation of pain. Electroencephalogr Clin Neurophysiol 1998;107:227-253
12. Kern MK, Birn RM, Jaradeh S, Jesmanowicz A, Cox RW, Hyde JS, Shaker R: Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology 1998;115:1353-1362.
13. Aziz Q, Andersson R, Valind S, Sundin A, Hamdy S, Jones AKP, Foster E, Langstrom B, Thompson DG: Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology 1997;113:50-59.
14. Ladabaum U, Minoshima S, Hasler WL, Cross D, Chey WD, Owyang C: Gastric distension correlates with activation of multiple cortical and subcortical regions. Gastroenterology 2001;120:369-376.
15. Vandenbergh J, Dupont P, Fischler B, Bormans G, Persoons P, Janssens J, Tack J: Regional brain activation during proximal stomach distention in humans: a positron emission tomography study. Gastroenterology 2005;128:564-573.
16. Lu CL, Wu YT, Yeh TC, Chen LF, Chang FY, Lee SD, Ho LT, Hsieh JC: Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil 2004;16:575-587.
17. Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997;112:64-72.
18. Ringel Y, Drossman AD, Turkington TG, Hawk TC, Bradshaw B, Coleman RE, Whitehead WE: Dysfunction of the motivational-affective pain system in patients with IBS: PET imaging in response to rectal balloon distension. Gastroenterology 2000B;118:A444.
19. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R: Regional cerebral activation in irritable bowel syndrome in control subjects with painful and nonpainful rectal distention. Gastroenterology 2000;118:842-848.
20. Kern MK, Arndorfer RC, Hyde JS, Shaker R: Cerebral cortical representation of external anal sphincter contraction: effect of effort. Am J Physiol 2004;286:G304-G311.
21. Derbyshire SW: Visceral afferent pathways and functional brain imaging. Scientific World-Journal 2003;3:1065-1080.
22. Bonaz B: Visceral sensitivity perturbation integration in the brain-gut axis in functional digestive disorders. J Physiol Pharmacol 2003;54(suppl 4):27-42.
23. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
24. Ringel Y, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H, Bangdiwala SI, Drossman DA: Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut 2004;53:838-842.
25. Naliboff BD, Derbyshire SWG, Munakata J, Berman S, Mandelkem MA, Chang L, Mayer EA: Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation. Psychosom Med 2001;63:365-375.
26. Mayer EA, Derdyshire S, Naliboff BD: Cerebral activation in irritable bowel syndrome. Gastroenterology 2000;119:1418.
27. Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, Fournet J, Segebarth C: Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 2002;97:654-661.
28. Bernstein CN, Frankenstein UN, Rawsthorne P, Pitz M, Summers R, McIntyre MC: Cortical mapping of visceral pain in patients with GI disorders using functional magnetic resonance imaging. Am J Gastroenterol 2002;97:319-327.
29. Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, Chang L: Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 2005;115:398-409.
30. Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, Vogt B, FitzGerald L, Mandelkern MA: Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003;98:1354-1361.
31. Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA: Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 2003;124:1738-1747.
32. Ringel Y, Drossman DA, Turkington TG, Bradshaw B, Hawk TC, Bangdiwala S, Coleman RE, Whitehead WE: Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci 2003;48:1774-1781.
33. Ringel Y, Drossman DA, Leserman J, Lin W, Liu H, Vogt B, Whitehead WE: Association of anterior cingulate cortex activation with psychosocial distress and pain reports. Gastroenterology 2003;124:A97.
34. 11C]methyl-L-tryptophan, positron emission tomography and statistical parametric mapping. Can J Gastroenterol 2003;17:191-196.
35. Diksic M: Labelled α-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system. J Psychiatry Neurosci 2001;26:293-303.
36. Chang L, Heitkemper MM: Gender differences in irritable bowel syndrome. Gastroenterology 2002;123:1686-1701.
37. Mayberg HS: Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65:193-207.
38. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT: Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057-1061.
39. Ketter TA, Wang PW: Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies. J Clin Psychiatry 2002;63(suppl 3):21-25.
40. Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, Whitehead W: Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003;124:754-761.
41. Spiller RC: Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999;107:91S-97S.
42. Talley NJ: Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 2003;56:362-369.
43. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, et al: The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002;159:728-737.
44. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, Mayer EA: The neural correlates of placebo effects: a disruption account. Neuroimage 2004;22:447-455.
45. 3 receptor antagonist alosetron. Gastroenterology 2002;123:969-977.
46. 3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Aliment Pharmacol Ther 2002;16:1357-1366.
47. 3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome. Neurogastroenterol Motil 2005;17:212-221.
48. Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li JZ, Koch GG, Bangdiwala SI: Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
49. Morgan V, Pickens D, Gautam S, Kessler R, Mertz H: Amitriptyline reduces rectal pain-related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005;54:601-607.
50. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T: Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005;331:435.
51. Lackner JM, Lou Coad M, Mertz HR, Wack DS, Katz LA, Krasner SS, Firth R, Mahl TC, Lockwood AH: Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav Res Ther 2006;44:621-638.